ProUroCare Medical Inc. 4
4 · ProUroCare Medical Inc. · Filed Nov 1, 2013
Insider Transaction Report
Form 4
Myrum Stanton Dean
DirectorCEO
Transactions
- Purchase
Common Stock Warrant (right to buy)
2013-10-31→ 75,000 totalExercise: $0.50From: 2013-10-31Exp: 2016-10-01→ Common Stock (75,000 underlying) - Purchase
10% Convertible Promissory Note
2013-10-31$1.00/shExercise: $0.50From: 2013-10-31Exp: 2015-10-01→ Common Stock
Holdings
- 21,000
Common Stock, $0.00001 par value
- 77,600
Warrants
Exercise: $0.50Exp: 2018-05-08→ Common stock, $0.00001 par value (77,600 underlying) - 227,600
Warrants
Exercise: $0.50Exp: 2018-05-08→ Common stock, $0.00001 par value (150,000 underlying)
Footnotes (4)
- [F1]The warrants will vest and become exercisable upon the first to occur of (a)first commercialization of the Issuer's products or (b)a change of control of the Issuer.
- [F2]Subject to adjustment based on a predefined formula set forth in the 10% Secured Convertible Note.
- [F3]On October 31, 2013, the reporting person purchased $25,000, 10% secured convertible promissory note from the issuer in a private placement. The promissory note matures on October 1, 2015, however, the holders have an optional conversion at any time prior to maturity at an exercise price predetermined by a formula set forth in the promissory note.
- [F4]The number of underlying common shares of the issuer will be determined at the time of conversion based on a predefined formula set forth in the promissory note.